DEFINITIVE HEALTHCARE CORP
DHNASDAQTrading Snapshot
- Day Range
- $0.64 – $0.66
- 52-Week Range
- $0.62 – $4.35
- Volume
- $2.24B
- Avg Volume
- $2.04B
- Shares Outstanding
- 105.5M
- Next Earnings
- Oct 1, 2026
Fundamentals Snapshot
- Annual Revenue
- $242M
- Last Q Revenue
- $55M
- P/E Ratio
- -0.4
- P/S Ratio
- 0.3x
- EPS (TTM)
- $-1.59
- Dividend Yield
- 0.00%
Why Investors Own DH
- ✓High-growth profile — revenue up +36.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 69% gross margin and 26% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About DEFINITIVE HEALTHCARE CORP
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
Otter Score Breakdown
ⓘAnalyst Price Target
ⓘLatest News & Updates
DEFINITIVE HEALTHCARE CORP tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift DH price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
DEFINITIVE HEALTHCARE CORP announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.